Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat
...• Raised $32.5 Million, Completing a $39.3 Million Private Placement
...Antibiotics were touted in headlines this week as a groundbreaking
A powerhouse pair of Vancouver cancer leaders, Drs. Simon Sutcliffe and Hal